Evidence map›Paper›PMID 34950631›Full record

ArticleFrontiers in public health2021

Carbon Ion Radiotherapy Evokes a Metabolic Reprogramming and Individualized Response in Prostate Cancer.

Renli Ning, Yulei Pei, Ping Li, Wei Hu, Yong Deng, Zhengshan Hong, Yun Sun, Qing Zhang, Xiaomao Guo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Inflammation and tumor microenvironment.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Renli NingDepartment of Research and Development, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.
Yulei PeiShanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Ping LiShanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Wei HuShanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Yong DengShanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Zhengshan HongShanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Yun SunDepartment of Research and Development, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.
Qing ZhangShanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Xiaomao GuoDepartment of Research and Development, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.
Center for High Pressure Science & Technology Advanced Research · CNFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heavy Ion RadiotherapyProstatic NeoplasmsArginineChromatography, LiquidHumansMaleTandem Mass SpectrometryArgininecarbon ion radiotherapyindividualized responsemetabolic reprogrammingmetabolite profilesmetabolitesprostate cancer

Identifiers

PMID34950631
PMCPMC8688694
OpenAlexW4200434412

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.